The Europe medical cannabis market is expected to reach US$ 13,801.0 million by 2028 from US$ 492.1 million in 2021. The market is estimated to grow with a CAGR of 61.1% from 2022 to 2028. The market growth is mainly attributed to factors such as increasing research activities on medicinal use of cannabis and increasing government funding and focus on cannabis use. However, the illegal use of cannabis as a street drug is likely to hinder market growth.

Significant number of countries are adopting medical cannabis laws, but it is rare for government officials to encourage health professionals to learn about cannabis herbal medicines. In 2016, various Cannabis experts were invited to Macedonia on the use of cannabis in clinical practice to train local health providers. The program was held in Skopje and was supported and financed by the Ministry of Health of Macedonia.

Cannabis offers unique opportunities in Macedonia, where the medical system is at a stage of evolution and modernization. Local medical specialists are now able to prescribe cannabis in the country. In view of this, Macedonian cannabis promoters have worked with local governments to set up a medical cannabis training program to support doctors and their patients. The momentum of the Macedonian medical cannabis movement is moving fast, and the public opinion on cannabis has also changed dramatically in the region. The revolution in medical marijuana in the region urges the European Commission and Member States to address regulatory, financial and cultural barriers that burden scientific research and encourage them to fund research.

Similarly, the government is granting funds to accelerate R&D activities on cannabis use for COVID-19. For instance, in September 2020, EXMceuticals Inc. announced receiving funds for focusing on R&D for landmark COVID-19 activities. The European Union and the Portuguese government have allocated funds of ~US$ 353,000 (EUR 302,000) to support the company’s BioBlockCOVID project, which aims to create functional, natural, and innovative biocide formulations targeting specific molecules that makeup COVID-19. It is expected that the funds would enhance the research activities and help in innovating newer techniques.

Thus, due to the above advancements, the medical cannabis market is expected to grow at a rapid pace during the forecast period.

Country Analysis

The prescription of medical cannabis for medical use was legalized in Germany in March 2017. There are different types of medicinal cannabis products found in Germany. German pharmacies are selling more medicinal cannabis to patients. According to Germany’s Federal Ministry of Health, sales have increased from 33.8 kg in the first six months of 2015 to 61.8 kg in the first six months of 2016. In addition, clinical studies with medical cannabis or single cannabinoids in different diseases are increasing. Sativex was licensed in Germany in 2011 as an add-on therapy for moderate-to-severe multiple sclerosis (MS) treatment-resistant spasticity symptoms. In Germany, Sativex clinical trials have proved that Sativex is a cost-effective treatment option for patients with MS spasticity.

Additionally, due to rising medical applications of medical cannabis, in July 2018, Germany’s Federal Institute for Drugs and Medical Devices (BfArM) permitted the growth of 10,400 kg of medical cannabis in Germany over the next four years. Owing to increased cultivation of medical cannabis and growing government support for medical cannabis cultivation drive the growth of the medical cannabis market.

The Centers for Disease Control and Prevention (CDC), National Library of Medicine, Prohibition Partners, State Agency for Medical Cannabis (SAKL), and Worldometer are among the primary and secondary sources referred to while preparing the report on the Europe medical cannabis market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Medical Cannabis Market– By Product Type
1.3.2 Europe Medical Cannabis Market– By Medical Application
2. Europe Medical Cannabis Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Primary Research
4. Europe Medical Cannabis– Market Landscape
4.1 Overview
4.1.1 Europe PEST Analysis
4.2 Expert Opinions
5. Europe Medical Cannabis Market– Key Industry Dynamics
5.1.1 Increasing Research Activities on Medicinal Use of Cannabis
5.1.2 Increasing Government Funding and Focus on Cannabis Use
5.2 Market Restraints
5.2.1 Illegal Cannabis Used as Street Drug
5.3 Market Opportunities
5.3.1 Growing Demand for Cannabis During COVID-19
5.4 Future Trends
5.4.1 Increased Acceptance and Distribution of Medical Cannabis
5.5 Impact analysis
6. Medical Cannabis Market– Europe Analysis
6.1 Europe Medical Cannabis Market Revenue Forecasts and Analysis
6.2 Company Analysis
6.2.1 Market Positioning of Key Players in Europe Medical Cannabis Market
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Aurora Cannabis, Inc.
6.2.4.2 Medical Marijuana Inc.
6.2.4.3 The Cronos Group
7. Medical Cannabis Market Analysis and Forecasts To 2028 – Product Type
7.1 Overview
7.2 Europe Medical Cannabis Market Share by Product Type 2021 & 2028 (%)
7.3 Flowers Market
7.3.1 Overview
7.3.2 Flowers Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Concentrates Market
7.4.1 Overview
7.4.2 Concentrates Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Cannabis Oil & Topical Ointments Market
7.5.1 Overview
7.5.2 Cannabis Oil & Topical Ointments Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Tablets Market
7.6.1 Overview
7.6.2 Tablets Market Revenue and Forecast to 2028 (US$ Mn)
7.7 Capsules Market
7.7.1 Overview
7.7.2 Capsules Market Revenue and Forecast to 2028 (US$ Mn)
7.8 Beverages and Edibles Market
7.8.1 Overview
7.8.2 Beverages and Edibles Market Revenue and Forecast to 2028 (US$ Mn)
8. Medical Cannabis Market Analysis and Forecasts To 2028 – Medical Application
8.1 Overview
8.2 Europe Medical Cannabis Market Share by Medical Application 2021 & 2028 (%)
8.3 Pain Management
8.3.1 Overview
8.3.1.1 Pain Management Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Neurological Health Management
8.4.1 Overview
8.4.1.1 Neurological Health Management Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Mental Health Management
8.5.1 Overview
8.5.1.1 Mental Health Management Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.1.1 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Medical Cannabis Market Analysis and Forecasts To 2028 – Compound
9.1 Overview
9.2 Europe Medical Cannabis Market Share by Compound 2021 & 2028 (%)
9.3 Tetrahydrocannabinol (THC)-Dominant Market
9.3.1 Overview
9.3.2 Tetrahydrocannabinol (THC)-Dominant Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cannabidiol (CBD)-Dominant Market
9.4.1 Overview
9.4.2 Cannabidiol (CBD)-Dominant Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Balanced THC and CBD Market
9.5.1 Overview
9.5.2 Balanced THC and CBD Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Medical Cannabis Market Revenue and Forecasts To 2028
10.1 Overview
10.2 Europe Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.3 Europe Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)
10.4 Europe Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)
10.5 Europe Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.6 Europe Medical Cannabis Market Revenue and Forecasts to 2021 to 2028, By Country (%)
10.6.1 Germany Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.1.1 Germany Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.1.2 Germany Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)
10.6.1.3 Germany Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)
10.6.1.4 Germany Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.6.2 Switzerland Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.2.1 Switzerland Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.2.2 Switzerland Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)
10.6.2.3 Switzerland Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)
10.6.2.4 Switzerland Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.6.3 Denmark Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.3.1 Denmark Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.3.2 Denmark Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)
10.6.3.3 Denmark Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)
10.6.3.4 Denmark Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.6.4 Poland Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.4.1 Poland Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.4.2 Poland Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)
10.6.4.3 Poland Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)
10.6.4.4 Poland Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.6.5 Malta Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.5.1 Malta Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
10.6.5.2 Malta Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)
10.6.5.3 Malta Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)0
10.6.5.4 Malta Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)1
10.6.6 Czechia Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)2
10.6.6.1 Czechia Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)3
10.6.6.2 Czechia Medical Cannabis Market Revenue and Forecasts, by Product Type (US$ Mn)4
10.6.6.3 Czechia Medical Cannabis Market Revenue and Forecasts, By Medical Application (US$ Mn)5
10.6.6.4 Czechia Medical Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)6
11. Impact of COVID-19 Pandemic on Europe Medical Cannabis Market7
11.1 Europe: Impact Assessment of COVID-19 Pandemic7
12. Medical Cannabis Market–Industry Landscape9
12.1 Organic Developments9
12.1.1 Overview9
12.2 Growth Strategies in the Europe Medical Cannabis Market0
12.2.1 Organic Developments Done by Companies1
12.3 Inorganic Developments3
12.3.1 Overview3
12.3.2 Inorganic Developments Done By Companies3
13. Company Profiles6
13.1 Aurora Cannabis Inc.6
13.1.1 Key Facts6
13.1.2 Business Description6
13.1.3 Products and Services7
13.1.4 Financial Overview7
13.1.5 SWOT Analysis9
13.1.6 Key Developments9
13.2 Cannabis Science, Inc1
13.2.1 Key Facts1
13.2.2 Business Description1
13.2.3 Products and Services2
13.2.4 Financial Overview2
13.2.5 SWOT Analysis3
13.2.6 Key Developments3
13.3 Canopy Growth Corporation4
13.3.1 Key Facts4
13.3.2 Business Description4
13.3.3 Products and Services5
13.3.4 Financial Overview5
13.3.5 SWOT Analysis7
13.3.6 Key Developments8
13.4 Medical Marijuana Inc9
13.4.1 Key Facts9
13.4.2 Business Description9
13.4.3 Products and Services9
13.4.4 Financial Overview0
13.4.5 SWOT Analysis1
13.4.6 Key Developments2
13.5 VIVO Cannabis Inc3
13.5.1 Key Facts3
13.5.2 Business Description3
13.5.3 Products and Services4
13.5.4 Financial Overview4
13.5.5 SWOT Analysis6
13.5.6 Key Developments7
13.6 Tikun Olam8
13.6.1 Key Facts8
13.6.2 Business Description8
13.6.3 Products and Services8
13.6.4 Financial Overview8
13.6.5 SWOT Analysis9
13.6.6 Key Developments0
13.7 Tilray1
13.7.1 Key Facts1
13.7.2 Business Description1
13.7.3 Products and Services2
13.7.4 Financial Overview2
13.7.5 SWOT Analysis5
13.7.6 Key Developments6
13.8 The Cronos Group7
13.8.1 Key Facts7
13.8.2 Business Description7
13.8.3 Products and Services8
13.8.4 Financial Overview8
13.8.5 SWOT Analysis1
13.8.6 Key Developments2
13.9 CANVORY3
13.9.1 Key Facts3
13.9.2 Business Description3
13.9.3 Products and Services4
13.9.4 Financial Overview5
13.9.5 SWOT Analysis5
13.9.6 Key Developments5
13.10 Organigram Holdings Inc.6
13.10.1 Key Facts6
13.10.2 Business Description6
13.10.3 Products and Services6
13.10.4 Financial Overview7
13.10.5 SWOT Analysis8
13.10.6 Key Developments8
14. Appendix9
14.1 About The Insight Partners9
14.2 Glossary of Terms9

LIST OF TABLES

Table 1. Europe Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)
Table 2. Europe Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)
Table 3. Europe Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)
Table 4. Germany Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)
Table 5. Germany Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)
Table 6. Germany Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)
Table 7. Switzerland Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)
Table 8. Switzerland Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)
Table 9. Switzerland Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)
Table 10. Denmark Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)
Table 11. Denmark Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)
Table 12. Denmark Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)
Table 13. Poland Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)
Table 14. Poland Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)
Table 15. Poland Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)
Table 16. Malta Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)
Table 17. Malta Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)0
Table 18. Malta Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)1
Table 19. Czechia Medical Cannabis Market Revenue and Forecasts To 2028, By Product Type (US$ Mn)4
Table 20. Czechia Medical Cannabis Market Revenue And Forecasts To 2028, By Medical Application (US$ Mn)5
Table 21. Czechia Medical Cannabis Market Revenue and Forecasts To 2028, By Compound (US$ Mn)6
Table 22. Recent Organic Growth Strategies in the Europe Medical Cannabis Market1
Table 23. Glossary of Terms, Medical Cannabis Market9

LIST OF FIGURES

Figure 1. Medical Cannabis Market Segmentation
Figure 2. Medical Cannabis Segmentation, By Country
Figure 3. Flowers Segment Held Largest Share Of The Product Type Segment In Medical Cannabis Market
Figure 4. Europe Medical Cannabis Market, By Country (US$ Mn)
Figure 5. Europe Medical Cannabis Market, Industry Landscape
Figure 6. Europe: PEST Analysis
Figure 7. Europe Medical Cannabis Market– Revenue Forecasts and Analysis – 2022- 2028
Figure 8. Market Positioning of Key Players in Europe Medical Cannabis Market
Figure 9. Europe Medical Cannabis Market – Comparative Company Analysis
Figure 10. Europe medical cannabis Market – Growth Strategy Analysis
Figure 11. Europe Medical Cannabis Market Share by Product Type 2021 & 2028 (%)
Figure 12. Flowers Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 13. Concentrates Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 14. Cannabis Oil & Topical Ointments Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 15. Tablets Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 16. Capsules Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 17. Beverages and Edibles Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 18. Europe Medical Cannabis Market Share by Medical Application, 2021 & 2028 (%)
Figure 19. Pain Management Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Neurological Health Management Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Mental Health Management Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Europe Medical Cannabis Market Share by Compound 2021 & 2028 (%)
Figure 24. Tetrahydrocannabinol (THC)-Dominant Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 25. Cannabidiol (CBD)-Dominant Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Balanced THC and CBD Market Revenue And Forecasts To 2028 (US$ Mn)
Figure 27. Europe Medical Cannabis Market Revenue, By Country, 2019 (US$ MN)
Figure 28. Europe Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. Europe Medical Cannabis Market Revenue and Forecasts 2021 to 2028, By Country (%)
Figure 30. Germany Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. Switzerland Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. Denmark Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. Poland Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34. Malta Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. Spain Medical Cannabis Market Revenue and Forecasts To 2028 (US$ Mn)3
Figure 36. Impact of COVID-19 Pandemic on Medical Cannabis Market in European Countries8
Figure 37. Growth Strategies in the Europe Medical Cannabis Market0

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe medical cannabis market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe medical cannabis market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies – Europe Medical Cannabis Market
1. Organigram Holdings Inc
2. Aurora Cannabis Inc
3. Cannabis Science, Inc
4. Canopy Growth Corporation
5. Medical Marijuana Inc
6. VIVO Cannabis Inc
7. Tikun Olam
8. Tilray
9. The Cronos Group
10. Canvory

Rising Research Activities on Medicinal Use of Cannabis to Drive Europe Medical Cannabis Market

According to a new research study titled “Europe Medical Cannabis Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type, Medical Application, and Compound,” the market is expected to grow from US$ 492.1 million in 2021 to US$ 13,801.0 million by 2028. It is estimated to grow at a CAGR of 61.1% from 2022 to 2028. The report highlights trends prevailing in the market along with drivers and hindrances pertaining to the Europe medical cannabis market growth.

Cannabis belongs to the cannabaceae family. Cannabis is also known with other names such as grass, pot, hash, weed, reefer, dope, herb, mull, buddha, ganja, joint, stick, buckets, cones, skunk, hydro, yarndi, smoke and hooch. Cannabis has long been used as vegetables and as juice, medicinal purposes and as a recreational drug. Cannabis is basically a drug that is obtained from Indian hemp plants named Cannabis indica and Cannabis sativa. There are different forms of cannabis available such as marijuana, hashish, and Hash oil. Some species of cannabis are used to produce hemp fiber for use in paper, textiles, and clothing. Cannabis is used for medical purposes for many years. Recent studies show that cannabis may be useful to help conditions such as nausea and vomiting, particularly when associated with chemotherapy, glaucoma, epilepsy, and asthma.

Factors, such as the increasing research activities on medicinal use of cannabis and increasing government funding and focus on cannabis use are driving the growth of the Europe medical cannabis market. However, illegal use of cannabis as street drug is hampering the market growth. With the legalization of cannabis in Europe, producers are increasingly looking for quick and accurate means to determine the quality and potency of their products. Increasing use of cannabis is propelling the demand for cannabis testing. The European Parliament is calling for an EU-wide policy on medical cannabis and well-funded scientific research.

Poland dominated the Europe medical cannabis market. The market is majorly driven owing to surge in developments by market players and noticeable support of European governments in promoting medical cannabis cultivation. In January 2022, according to the data released by Prohibition Partners, Poland is home to more than 9,261 patients legally accessing medical cannabis, one of the largest populations in Europe. Demand for medical cannabis from patients in Poland is growing fast, but the government still fails to ensure adequate supply. The Parliament has rejected new legislation that would bolster the national supply. In August 2022, Tilray Brands announced its unit Tilray Medical received approval to commercialize its medical cannabis products in Poland. The company announced that Tilray Medical had established multiple partnerships with pharmaceutical companies to distribute both Tilray branded and unbranded medical cannabis products in Poland. In May 2022, PharmaCielo Ltd., the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, and PharmaCielo Colombia Holdings S.A.S. signed an investment agreement with Soteria Holdings Limited, a UK-based portfolio company of Artemis Growth Partners, an established E.S.G. and impacted investor focused on the cannabis industry worldwide. According to the Agreement, Soteria’s Polish operating subsidiary will apply for a few licenses to import and wholesale the company’s medical cannabis flower and extracts in the Polish market. Furthermore, Soteria’s Polish subsidiary will support a group of the country’s leading medical cannabis professionals to provide education and training programs to doctors in Poland looking to prescribe medical cannabis to their patients. In August 2022, Curaleaf International’s product registration in Poland will help to meet the increasing demand for cannabis medicine in the country. According to Prohibition Partners, Poland is currently one of Europe’s largest medical cannabis markets by patient size.

Aphria, Inc; Aurora Cannabis; Cannabis Science, Inc; Canopy Growth Corporation; Medical Marijuana, Inc; VIVO Cannabis Inc; Tikum Olam; Tilray; The Cronos Group; and Canvory are among the key companies operating in the Europe medical cannabis market.

Global Europe medical cannabis Market, by Region, 2022 (%)

Source: The Insight Partners Analysis

The Europe medical cannabis market is further segmented into Germany, Poland, Denmark, Switzerland, Malta, Czechia, and the Rest of Europe.